Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cariogenic bacteria are a diverse group of microorganisms that contribute to the development of dental caries by fermenting dietary carbohydrates and producing acids that demineralize tooth enamel. Key species include *Streptococcus mutans*, *Streptococcus sobrinus*, and *Lactobacillus* species. These bacteria possess virulence factors such as acidogenicity, aciduricity, and the ability to form biofilms. While *S. mutans* has been historically emphasized, dental caries is now understood to result from a complex interplay of multiple acid-producing and acid-tolerant organisms. Prevention strategies focus on controlling these microbial populations through methods like improved oral hygiene, dietary modifications, fluoride application, and antimicrobial agents.
Antibiotics: Bacterial cell wall disruption or inhibition of protein synthesis. Fluoride: Enhances enamel remineralization and inhibits bacterial enzyme activity. Xylitol: Inhibits sugar metabolism and reduces acid production.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cariogenic Bacteria.